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Abstract
Purpose: The pattern of immune cells infiltrating the cor-
neal stroma has been extensively studied in mice, but data 
on human tissue have been far less elaborate. To further 
characterize the number and differentiation state of resident 
immune cells in organ-cultured human corneal tissue, we 
employed a comprehensive bioinformatic deconvolution 
(xCell) of bulk RNA-sequencing (RNA-seq) data, immunohis-
tochemistry (IHC), and flow cytometry (FC). Methods: A tran-
scriptome-based analysis of immune cell types in human 
corneal samples was performed. The results were validated 
by IHC, focusing on the identification of pro-inflammatory 
(M1) and regulatory (M2) macrophages. A protocol was es-
tablished to identify these 2 different macrophage popula-
tions in human corneal tissue by means of FC. Subsequently, 
corneal samples in organ culture were differentially stimu-
lated by IL-10, IL-4 & IL-13, or LPS and macrophage popula-
tions were evaluated regarding their response to these stim-
uli. Furthermore, cell survival was analyzed in correlation 
with time in organ culture. Results: xCell-based mathemati-
cal deconvolution of bulk RNA-seq data revealed the pres-
ence of CD8 T cells, Th17 cells, dendritic cells, and macro-
phages as the predominant immune cell types in organ-cul-
tured human corneal tissue. Furthermore, RNA-seq allowed 
the detection of different macrophage marker genes in cor-
neal samples, including PTPRC (CD45), ITGAM (CD11b), CD14, 
and CD74. Our RNA-seq data showed no evidence of a rele-
vant presence of monocytes in human corneal tissue. The 
presence of different macrophage subtypes was confirmed 
by IHC. The disintegration and subsequent FC analysis of hu-
man corneal samples showed the presence of both M1 (HLA-
DR+, CD282+, CD86+, and CD284+) and M2 (CD163+ and 
CD206+) macrophage subtypes. Furthermore, we found that 
the total number of macrophages in corneal samples de-
creased more than the total cell count with increasing tissue 
culture time. Treatment with IL-10 led to higher total cell 
counts per cornea and to an increased expression of the M2 
marker CD163 (p < 0.05) while expression levels of various 
M1 macrophage markers were not significantly reduced by 
interleukin treatment. Conclusions: Regarding different 
macrophage populations, untreated human corneas showed 
more M1 than M2 macrophages. With increasing organ cul-
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ture time, these macrophages decreased. In terms of cell dy-
namics, adding interleukins to the organ culture medium in-
fluenced the phenotype of macrophages within the cornea 
as detected by FC. Modifying the immunomodulatory prop-
erties of human grafts appears a promising approach to fur-
ther reduce the risk of graft rejection in patients. In this con-
text, treatment with interleukins was more effective in up-
regulating M2 macrophages than in suppressing M1 
macrophages in corneal tissue. © 2021 The Author(s).
Published by S. Karger AG, Basel
Introduction
Despite its transparency, the human cornea contains 
various cell types, including both differentiated and un-
differentiated immune cells. Among these cells, CD8 T 
cells, dendritic cells (DC), and macrophages take on a 
special role [1, 2]. Even though the innate immune cells 
are considered to be tissue resident, especially macro-
phages and DC can traffic in and out of the cornea in the 
steady state and translocate to locoregional lymph nodes 
following corneal transplantation [3, 4]. Especially dur-
ing corneal graft rejection, donor antigen-presenting cells 
(APCs) leave the graft and interact with the recipient’s 
immune system (direct pathway), just as recipient APCs 
can enter the graft, take up and process alloantigens, and 
induce consecutive immune responses (indirect path-
way) [5]. In humans, the role and contribution of the 2 
different pathways in corneal graft rejection is not yet ful-
ly understood, nor is the role of the phenotype of the cells 
present in the graft at the time of transplantation.
Identification, localization, and phenotyping of APCs 
in the human cornea remain an experimental bottleneck 
in this context. Furthermore, the innate immune cell pro-
file of the human cornea seems to be a moving target – 
altered not only by corneal graft rejection but also by un-
derlying diseases of the cornea and the ocular surface [6]. 
Early work describing the cellular composition of the hu-
man cornea mainly focused on histology and immuno-
histochemistry [7] as well as confocal microscopy [8, 9]. 
However, these approaches do not allow a simultaneous 
analysis of several parameters of macrophages as a sub-
stantial part of the corneal immune system. Recent ap-
proaches therefore focus on immunophenotyping using 
RNA-sequencing (RNA-seq) [2] and flow cytometry 
(FC) [10].
Human corneas are kept in organ culture for several 
days to weeks before transplantation. One approach to 
overcome graft rejection mediated by the direct route 
may be to add supplements to the cell culture to shape the 
phenotype of immune cells within the graft. In mice, in-
cubation of donor corneas with IL-10 and TGF-β altered 
the graft-APC-phenotype and has been shown to im-
prove allograft survival [11]. If this were also true for hu-
man APC in corneal tissue, it would offer an additional 
therapeutic option for patients with increased risk for 
corneal graft rejection.
Currently, the composition of immune cells in the hu-
man cornea is underinvestigated. The present knowledge 
is mostly restricted to murine data and to adaptive rather 
than innate immune cells. Moreover, the current FC pro-
tocols appear to be little or not at all standardized. In the 
present study, we therefore performed RNA-seq on for-
malin-fixed and paraffin-embedded (FFPE) healthy cor-
neas and established a FC protocol for processing and 
phenotyping human corneal cells. We investigated which 
macrophage subtypes were present in the human cornea, 
with special focus on pro-inflammatory (M1) and regula-
tory (M2) macrophages. We also analyzed the functional 
response of these cells to different interleukins and as-
sessed the APC differentiation state in organ culture.
Materials and Methods
Ethics
Ethics approval was granted by the local Ethics Committee (Re-
search Ethics Committee of University of Freiburg; Germany; ref-
erence numbers: 572/14 and 25/20). This study adheres to the te-
nets of the Declaration of Helsinki.
RNA Extraction
Corneal samples were dissected from 2 enucleated eyes (due to 
ciliary body melanoma), as well as from 1 corneal explant (due to 
corneal endothelial failure), which were FFPE immediately after 
surgery, as previously described [12]. Samples were fixed immedi-
ately after surgery in 4% formalin for 12 h, dehydrated in alcohol, 
and processed for paraffin embedding. Histological diagnoses 
were made by 2 experienced ophthalmic pathologists. 10 to 15 
FFPE sections (4 µm thick) from each cornea were collected and 
stored in tubes until RNA isolation, which was performed as previ-
ously described [12]. Briefly, total RNA was isolated from FFPE 
samples using the Quick-RNA FFPE Kit (Zymo Research). Follow-
ing a DNAse I digestion using the Baseline-ZERO kit (Epicentre), 
the RNA concentration was measured with the Qubit RNA HS 
Assay Kit on a Qubit Fluorometer (Life Technologies). The RNA 
quality was determined with the RNA Pico Sensitivity Assay on a 
LabChip GXII Touch (PerkinElmer).
RNA-Sequencing
RNA-sequencing was performed using massive analysis of 
cDNA ends (MACE), a 3′ RNA-sequencing method as previously 
described [13]. Briefly, 3 barcoded libraries were sequenced simul-
taneously on the NextSeq 500 (Illumina). PCR bias was removed 
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based on unique molecular identifiers encoded in the library bar-
codes. The sequencing data are available in the Gene Expression 
Omnibus Database under the accession number GSE164192.
Bioinformatics
Sequencing data (fastq files) were uploaded to and analyzed on 
the Galaxy web platform (https://usegalaxy.eu/) [14]. Quality con-
trol was performed with FastQC Galaxy Version 0.72 (http://www.
bioinformatics.babraham.ac.uk/projects/fastqc/ last access on De-
cember, 21 2020). Reads were mapped to the human reference ge-
nome (Gencode, release 36, hg38) with RNA STAR Galaxy Ver-
sion 2.7.6a [15] with default parameters using the Gencode anno-
tation file (Gencode, release 36, https://www.gencodegenes.org/
human/releases.html). Reads mapped to the human reference ge-
nome were counted using featureCounts Galaxy Version 2.0.1 [16] 
with default parameters using the aforementioned annotation file. 
The output of featureCounts was imported to RStudio (Version 
1.2.1335, R Version 3.5.3). Gene symbols were determined based 
on ENSEMBL release 101 (Human genes, GRCh38.p13, down-
loaded on November 23, 2020) [17]. Transcripts per million were 
calculated based on the output of featureCounts (assigned reads 
and feature length), as previously described [18]. Immune cell 
types enriched in corneal samples were determined using bioinfor-
matic deconvolution analysis. For this purpose the tool xCell [19] 
was applied, using the implemented Bindea cell signature. The re-
sults were filtered for immune cell types. Heatmaps were created 
with the R package ComplexHeatmap 1.20.0 [20]. Other data vi-
sualization was performed using the ggplot2 package [21].
Immunofluorescence
For immunofluorescence staining, 3 macroscopically normal 
eyes from 2 female and 1 male body donors were analyzed. The 
eyes were enucleated in accordance with the informed consent of 
body donors, which was contractually secured during lifetime. In 
accordance with ethical requirements, no data other than age, sex, 
body weight, and cause of death were recorded. Enucleation, tissue 
preparation, and staining were performed at the Institute of Anat-
omy, Leipzig University. Eyes were fixed in 4% PFA for 16 h at 4°C 
and dissected under a binocular microscope. Corneas were har-
vested, dehydrated in 30% sucrose and embedded in Tissue-Tek® 
O.C.T.TM Compound (Sakura Finetek Germany GmbH) for 
cryosections. 12 µm sections were blocked with 2% bovine serum 
albumin (BSA) and 2% normal donkey serum (NDS) in PBS Tri-
ton-X 0.1% for 60 min at room temperature. Primary antibodies 
were added at a dilution of 1:100 for CD206 (ab64693, Abcam), 
1:200 for HLA-DP, DQ, DR (M0775, DAKO), and 1:500 for IBA1 
(ab5076, Abcam) in PBS containing 2% BSA and 2% NDS in PBS 
Triton-X 0.1% overnight at 4°C. Following washing with 2% BSA 
and 0.2% NDS in PBS Triton-X 0.1%, secondary antibodies were 
added at a dilution of 1:500 (Alexa Fluor® 568 and Alexa Fluor® 
647, Thermo Fisher Scientific) in PBS Triton-X 0.1% at room tem-
perature for 90 min in the dark. After washing at least 3 times with 
2% BSA and 0.2% NDS in PBS Triton-X 0.1%, the slides were coun-
terstained with 4′,6-diamidino-2-phenylindole (DAPI) 1:10,000 
for 10 min, washed 3 times with PBS followed by autofluorescence 
quenching with TrueBlack® Lipofuscin Autofluorescence 
Quencher (Biotium) according to the manufacturers’ instructions. 
Slides were imaged using a Fluoview FV 1000 confocal microscope 
(Olympus) equipped with a 20 × 0.75 NA U Plan S Apo and 40 × 
0.95 NA U Plan S (Olympus).
Corneal Samples Acquisition for FC
Human corneas were received from the Lions Cornea Bank 
Baden-Württemberg (Freiburg im Breisgau, Germany). Corneas 
not suitable for transplantation due to a reduced corneal endothe-
lial cell count (endothelial cell count between 1,000 and 2,000 cells/
m2) or cornea remnants following Descemet’s membrane endo-
thelial keratoplasty implant preparation were used as previously 
described [22]. Informed consent by the donor or next of kin for 
scientific use was prerequisite for study enrollment. Corneas from 
donors with transmissible diseases were excluded from the exper-
iments according to the list of contraindications of infectious ori-
gin endorsed by the European Eye bank Association (https://www.
eeba.eu/minimum-medical-standards-revision-5.html).
After collection, corneas were stored in the eye bank in Tissue-
C medium (reference TIS 001-00, ALCHIMIA, Italy) with 2% FCS 
at 37°C and 5% CO2. In general, the organ medium was changed 
weekly. An exception to this are the experiments related to the cell 
content of the culture medium. In this case, the objective was to 
achieve maximum culture duration. The manufacturer indicates a 
theoretical culture duration of up to 6 weeks; in the respective ex-
periments, the corneas were maintained for 45 days ± 5.9 (mean ± 
SD). The culture medium supernatants as well as the pH were 
checked regularly to exclude contamination. For experiments in-
volving medium containing dextran, the corneas were cut in half 
and one half was incubated in the aforementioned Tissue-C me-
dium, the other half in Carry-C medium (containing 5% dextran, 
reference CAR 001-00, ALCHIMIA, Italy) for 24 h in the incubator 
as under the above conditions.
Stimulation
Central corneas were trephined with a 9.5-mm trephine; cor-
neo-scleral rims were not used. Corneal buttons were flattened by 
4 radial cuts toward the center. Corneas were immersed in a 12-
well plate (Thermo Fischer Scientific, Ref. 150628) with 3 mL tis-
sue culture medium (CARRY-C, Alchimia, Ref. CAR 001-00) and 
the appropriate stimulus (Table 1) at 37°C and 5% CO2 for 24 h, 
respectively. LPS and IL-10 were each used separately as stimuli, 
whereas IL-4 and IL-13 were used in combination. Untreated cor-
neas were incubated without a stimulus and served as controls.
Processing of Human Corneal Samples for FC
After stimulation corneas were removed from the well and 
rinsed with PBS (Gibco, Ref. 10010023). All corneas were de-epi-
thelialized before cutting. Descemet’s membrane of the cornea of 
samples from the eye bank were cautiously peeled off and com-
pletely removed, similar to the preparation for DMEK. Corneas 







LPS 1 mg/mL 100 Sigma Ref. L4391
IL-13 2 μg/mL 20 Peprotech Ref. 200-13
IL-4 5 μg/mL 40 Peprotech Ref. 200-04
IL-10 2 μg/mL 30 Peprotech Ref. 200-10
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were placed into a 12-well plate and covered with 1.1 mg/mL col-
lagenase D (Roche, Ref. 11088866001) in HBSS w/o CaCl2 and 
MgCl2 (Gibco, Ref. 14170-088) and incubated overnight at 37°C 
and 5% CO2. The following day, fragments were resuspended vig-
orously and sheared through a cell strainer (70-µm nylon mesh, 
Falcon, Ref. 352350) into a 50 mL FALCON tube; the strainer was 
again rinsed with 10 mM EDTA (Serva, Cat.11280) in PBS. The 
resulting cell suspension was centrifuged at 4°C and 450 g for 15 
min. The supernatant was discarded and the cells were transferred 
to a FC tube. The cell pellet was washed twice with 300 µL DPBS 
(Biotech, Ref. P04-35500) and resuspended in a FC tube for further 
use.
Flow Cytometry
To discriminate dead cells, 1 μL viability dye (Fixable viability 
stain 780, BD Horizon, Ref. 565388) was used according to the 
manufacturer’s instructions. Afterward the cell suspension was 
washed with 2 mL FC buffer (2% FBS with 10 mM EDTA in DPBS) 
once, centrifuged for 7 min at 450 g at 4°C.
Before antibody staining, 20 µL blocking solution (FcR block-
ing reagent (human), MACS, Ref. 130-059-901) was added. The 
sample was incubated for 5 min at room temperature. In a next 
step, the antibodies were added to each tube (all diluted in a 1:100 
dilution in FC buffer (2% FBS with 10 mM EDTA in DPBS; Ta-
ble 2). Samples were vortexed and covered for 20 min on ice. After 
incubation the cell pellet was washed in 2 mL FC buffer, centri-
fuged for 7 min at 450 g, the supernatant was discarded. For fixa-
tion, 100 µL intracellular fixation buffer (eBioscienceTM IC Fixation 
Buffer, Formaldehyde, Invitrogen, Ref. 00-8222-49) was added 
and incubated for 40 min at room temperature.
CD68 requires an intracellular staining protocol. Therefore, 
the cell pellet was washed after fixation with 2 mL 1x permeabiliza-
tion buffer (eBioscienceTM Permeabilization Buffer (10X), Invitro-
gen, Ref. 00-8333-56), centrifuged at 400 g for 5 min at 4°C. There-
after anti-CD68 was added in 100 µL permeabilization buffer and 
incubated for 30 min at room temperature and protected from 
light. After the incubation, cells were washed with 2 mL 1× per-
meabilization buffer once and the pellet was resuspended in 150 
µL FC buffer for analysis with CytoFLEX S FC (Beckman Coulter, 
Brea, CA, USA).
Gating Strategy
Cells were harvested from enzymatically digested human cor-
neas as mentioned above. Cells were identified using the FCS-A 
and SSC-A; singlets were then detected in an FSC-H and FSC-W 
combined gate. Alive cells were gated by means of viability dye. 
Leukocytes were identified according to CD45 expression. Macro-
phages were identified by means of CD11b, CD14, and CD68 ex-
pression. A sequential gating strategy was used to identify macro-
phage subsets based on their surface markers, HLA-DR+, CD282+, 
CD86+, and CD284+ cells were identified as M1 macrophages, 
whereas CD163+ and CD206+ cells were identified as M2 macro-
phages. After CD45+ myeloid cells were identified, fluorescence 
minus one (FMO) staining was applied to identify positive cells for 
the respective aforementioned surface markers.
Data Analysis and Plotting
FC data analysis was carried out using both FlowJo software 
(Version 10.6.2) and GraphPad Prism (GraphPad Software, Ver-
sion 6.0; La Jolla, USA). Data were analyzed descriptively using the 
R system [23], package ggplot2 [21], and Hmisc [24]. FC data are 
presented as exact cell count, as percentage (the percentage of pos-
itive cells from its parent gate), or per scale (per 50,000 alive cells). 
For data plotting the R platform, FlowJo software and GraphPad 
Prism were used. Box-whisker plots are plotted as median with 
quartiles. For statistical analysis the respective tests are mentioned 
in the figure legend.
Table 2. FC antibodies
Antibody Aliases Description Company Ref. ID
Anti-CD11b Integrin α-M BV711 rat anti-CD11b BD Horizon 563168
Anti-CD14 LPS receptor BV711 mouse anti-human CD14 BD Horizon 563373
Anti-CD45 PTPRC BV510 mouse anti-human CD45 BD Horizon 563204
Anti-CD68 GP110 BV711 mouse anti-human CD68 BD Horizon 565594
Anti-CD86 B7-2/ B70 APC mouse anti-human CD86 BD Horizon 560956
Anti-CD163 M130 PE-CF594 mouse anti-human CD163 BD Horizon 562670
Anti-CD206 MMR BB515 mouse anti-human CD206 BD Horizon 564668
Anti-CD282 TLR2 BV421 mouse anti-human CD282 BD Horizon 565350
Anti-CD284 TLR4 PE mouse anti-human TLR4 CD284 BD Horizon 564215
Anti-HLA-DR MHC class II receptor BB700 mouse anti-human HLA-DR BD Horizon 745782
FC, flow cytometry.
Fig. 1. a RNA-seq and immunofluorescence. RNA-seq indicated 
the presence of various immune cells in the human cornea; notably 
CD8+ T cells, Th17 cells, dendritic cells, and macrophages (n = 3 
individual corneas). b Besides PTPRC (CD45), macrophage-spe-
cific marker genes, such as ITGAM (CD11b), CD14, and CD74, can 
be detected by RNA-seq. c Immunofluorescence confirms the 
presence of M1 and M2 macrophages, with M1 macrophages ap-
pearing to be more abundant than M2 macrophages (representa-
tive images from 3 individual human corneas). RNA-seq, RNA-
sequencing; M1, pro-inflammatory macrophages; M2, regulatory 
macrophages.
(For figure see next page.)
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RNA-Seq and Immunofluorescence of Human Corneal 
Tissue
Bulk RNA-seq (online suppl. Fig. 1; for all online suppl. 
material, see www.karger.com/doi/10.1159/000516669) 
revealed various genes being strongly expressed in cor-
neal tissue, including genes that are known to be relevant 
in corneal cell signaling, such as S100A6 and S100A4 [25], 
KERA, coding for keratocan, a protein essential for main-
taining corneal shape and transparency [26], TGFBI, mu-
tations of which are involved in various corneal dystro-
phies [27], and ANGPTL7, which maintains corneal avas-
cularity [28]. Profiles of different adaptive and innate 
immune cell types were identified in the transcriptional 
profile of 3 healthy corneas using the xCell deconvolution 
tool. A particularly high xCell score was found for CD8+ 
T cells and Th17 cells, as well as for DCs and macrophages 
(Fig. 1a). In line with this, we identified several genes by 
RNA-seq that are typically expressed in macrophages, in-
cluding PTPRC (CD45), ITGAM (CD11b), CD14 – which 
were later applied for FACS-based identification of mac-
rophages – and CD74 (Fig. 1b).
Results from RNA-seq were confirmed using immu-
nofluorescence. In addition to IBA1 (AIF-1), co-staining 
with either MHC II (HLA-DRA) for identification of M1 
macrophages or CD206 (MRC1) for identification of M2 
macrophages was used (Fig. 1c). Staining with IBA1 re-
vealed staining of cells in both the anterior and posterior 
stroma in all 3 corneas. This was confirmed by co-stain-
ing with MHC II, which also showed double positive 
staining of cells in all parts of the stroma. As in the stain-
ing with MHC II, positive cells were also found in the 
double staining of IBA1 with CD206.
FC Analysis of Corneal Tissue
In addition to qualitative analysis, FC allows quantita-
tive ex vivo analysis. In a further approach, RNA-seq and 
immunofluorescence were therefore extended by FC 
analysis. For this purpose, we established a FACS proto-
col for human corneal tissue (Fig. 2). After identification 
of cells, duplicates and doublets were excluded. Subse-
quently, identification of living cells was performed with 
the aid of viability dye. Leukocytes were gated using CD45 
staining followed by the corresponding receptors CD11b 
and CD14 as well as CD68, based on our RNA-seq analy-
sis, to identify cornea macrophages. To further subdivide 
the macrophages, HLA-DR, CD282, CD284, and CD86 
were then used to identify M1 macrophages, whereas 
CD206 and CD163 were used for M2 macrophages 
(Fig. 2). In order to increase the precision of our gating 
strategy, FMO control was performed (red dots in Fig. 2). 
FMO controls showed a clear separation of the individu-
al populations for most fluorochromes, except for anti-
CD86. No distinct signal could be detected for CD86 in 
most of the samples, even when using the FMO control 
to set the baseline. Unstimulated corneal samples showed 
a ratio of M1 to M2 macrophages within CD45+ leuko-
cytes of approximately two-thirds to one-thirds (online 
suppl. Fig. 4).
Given the cellular composition of the cornea, we aimed 
to explore if additional staining with CD45 as a pan-leu-
kocyte marker would lead to a higher quality of the FACS 
data or whether this marker can be omitted. We therefore 
compared our FMO controls without (A in online suppl. 
Fig. 2) and with CD45 staining (B in online suppl. Fig. 2). 
We were furthermore interested to see if a CD45 staining 
would help to exclude other cells such as keratocytes. 
When staining with an anti-CD45 antibody, all FMO 
controls showed a more distinct differentiation from the 
positive population (online suppl. Fig. 2b) than samples 
without anti-CD45 antibody staining (online suppl. Fig. 
2a). Thus, CD45 proved to be an advantageous marker for 
the identification of leukocytes in the human cornea.
Macrophages in Organ-Cultured Human Corneas
It has been reported that the number of APCs within 
the cornea decreases with increasing time in organ cul-
ture [29]. To investigate this phenomenon in more detail, 
we analyzed the number of macrophages per cornea in 
correlation with culture time (Fig. 3): 24 corneas with dif-
ferent incubation times were digested without any other 
intervention and analyzed by FC according to the proto-
col mentioned above. Analysis confirmed a slight de-
crease in total cell count per cornea with increasing incu-
Fig. 2. Gating strategy to identify macrophage subsets in human 
corneas. Cells were harvested from enzymatically digested human 
corneas. CD45+ was used to identify leukocytes after exclusion of 
debris, doublets, and dead cells. Macrophages were identified by 
means of CD11b, CD14, and CD68 expression. A sequential gating 
strategy was used to identify macrophage subsets based on their 
surface markers: HLA-DR+, CD282+, and CD284+ cells were 
identified as M1 macrophages, whereas CD163+ and CD206+ cells 
were identified as M2 macrophages. CD86+ was only rarely de-
tected. FMO controls (in red) of the corresponding gate (cells in 
light blue) were included to determine the baseline for positive 
events in the particular channels. FMO, fluorescence minus one; 
M1, pro-inflammatory macrophages; M2, regulatory macro-
phages.
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bation time (Fig. 3a). To verify whether this decrease is 
accompanied by an altered polarization of macrophages, 
we further analyzed the expression of the individual 
markers for M1 and M2 macrophages (Fig.  3b, c). We 
found that the relative cell loss of both M1 as well as M2 
macrophages over time was higher than the total cell loss.
There are different culture media used in cornea banks 
worldwide for various reasons. The main differences be-
tween the media used include the dextran content, with 
dextran leading to less swelling of the grafts or being used 
to de-swell grafts. We therefore aimed to explore whether 
the observed cell loss might be caused by culture media 
conditions. Therefore, we compared cell numbers in cor-
neal culture medium with and without dextran (Fig. 3d). 
Corneas were cut in half and one half was incubated for 
24 h in tissue-C (without dextran), the other half in carry-
C medium (containing 5% dextran). Corneal macro-
phages were then analyzed by FC as above. The expres-
sion of all macrophage markers mentioned above showed 
no statistically significant difference between the tissue-C 
group and the carry-C group (pairwise t-test, Fig. 3d).
To explore if the reduced number of cells – especially 
macrophages – in the cornea was caused by cells leaving 
the graft and floating in the organ culture medium, we 
investigated the culture medium in which the corneas 
were stored by FC (online suppl. Fig. 3). It turned out that 
although living macrophages were detected in the culture 
medium, the cell count of these cells alone in the medium 
cannot account for the cell loss detected in corneal tissue.
Differentiation of Human Corneal Macrophages in 
Organ Culture
To see if the phenotype of macrophages in the human 
cornea can be altered, in a next step either IL-10, a combi-
nation of IL-4 with IL-13, or LPS were added to the organ 
culture medium (Fig. 4). LPS is a native and well-charac-
terized stimulus for Toll-like receptor signaling in macro-
phages which served as a positive control [30]. Prior to the 
analysis of individual markers before and after stimula-
tion, we first tested for possible toxic effects of the stimu-
lation. Regarding the exact number of alive cells, the IL-10 
group interestingly showed significantly more living cells 
per cornea compared to the group of untreated corneal 
samples (p < 0.05, one-way ANOVA; Fig. 4a), suggesting 
that supplementation of IL-10 to organ culture medium 
either prolongs the survival of cells in the cornea or leads 
to proliferation of cells in the corneal tissue. There was no 
evidence for cytotoxic effects caused by the addition of 
interleukins or LPS to the organ culture medium.
In addition to total cell numbers per cornea, we also 
measured the number of macrophages, especially mono-
cyte-derived macrophages, as it might be influenced by 
individual treatments. To exclude any confounders in 
this context, first all CD45+ cells were gated as described 
above, macrophages, especially monocyte-derived mac-
rophages, were then defined as CD11b+CD14+CD68+ 
cells (Fig. 4b). Statistics were performed using one-way 
ANOVA. Since the total cell count varied between cor-
neas, macrophage counts were normalized to the total 
corneal cell counts (scaled per 50,000 viable cells). In the 
IL-10-treated group, a lower relative number of macro-
phages/ monocyte-derived macrophages were observed, 
although this difference was not statistically significant.
In the next step, the aforementioned pro-inflammato-
ry and regulatory markers of macrophages were analyzed 
after stimulation (Fig. 4c). A potential goal of an immu-
nomodulatory intervention would be, for example, deple-
tion of M1 or enrichment of M2 macrophages in corneal 
grafts. In CD45+CD11b+CD14+CD68+ macrophages, IL-
10 treatment upregulated the expression of the M2 mark-
er CD163 (one-way ANOVA, p < 0.05). LPS reduced 
CD206+ and CD163+ cells compared to all other groups, 
even though this effect was not statistically significant. 
For the other 4 pro-inflammatory markers, there was no 
statistically significant suppression by the interleukins 
and no significant upregulation by stimulation with LPS. 
From our experimental design, M1 macrophages appear 
to be less sensitive to modification than M2 macrophages.
Discussion
Despite its transparency, the cornea contains large 
numbers of immune cells which contribute to rejection 
following corneal transplantation [31]. Yet, there are no 
Fig. 3. Macrophages in organ-cultured human corneas. a The total 
cell count per cornea varied over a wide range and decreased with 
increasing time in the organ culture (n = 24). To assess whether the 
macrophage populations decrease over time, the number of mac-
rophages per 50,000 alive cells was analyzed at different time 
points. Corneas with different tissue culture times were digested 
and examined for cell marker expression (n = 24). Both, cells ex-
pressing pro-inflammatory (b) and regulatory markers (c) de-
creased with increasing time in organ culture. d To assess whether 
the cell culture conditions affected macrophages in human cor-
neas, media with and without dextran were compared. Cornea 
halves were kept in the 2 different media for 24 h, followed by tis-
sue processing and FC analysis (n = 10 per group). The presence 
or absence of dextran in tissue organ culture medium did not sig-
nificantly alter the marker expression patterns (d). FC, flow cy-
tometry.
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comprehensive studies characterizing these immune cells 
in human corneal tissue. In the present study, human cor-
neal tissue was assessed by RNA-seq revealing the pres-
ence of CD8+ T cells, Th17 cells, DCs, and macrophages. 
A detailed immunohistochemical analysis of these mac-
rophages confirmed the presence of M1 macrophages 
and M2 macrophages. Based on FC, our study substanti-
ates a suspected loss of these APCs with increasing dura-
tion of organ culture. Furthermore, we demonstrate that 
cytokine treatment of human cornea organ cultures can 
alter the phenotype of resident macrophages as has been 
suggested in mice [11], whereby M1 macrophages appear 
to be less sensitive to modifications than M2 macro-
phages. FC analysis of individual corneas may thus facili-
tate further development of tissue-priming strategies in 
human organ culture to diminish transplant rejection 
risks, as has been suggested based on murine data [11].
Sequencing of corneal tissue has only been performed 
in a few individual studies to date. These studies are main-
ly focusing on corneal diseases, such as Fuchs endothelial 
dystrophy [32], keratoconus [33], and herpetic infections 
[34], rather than a systemic analysis of cellular compo-
nents of the cornea. A current study is the first to use a 
complex single-cell RNA-seq approach to investigate the 
most diverse cell populations of the cornea and the adja-
cent limbus in humans [2]. In this study, similar to our 
results, predominantly monocyte-derived macrophages 
and DCs were found, as well as CD8+ T cells and various 
macrophage subpopulations. This is in line with another 
study using single-cell and bulk RNA-seq paired with 
turnover studies in mice showing a steady replacement of 
resident tissue macrophages in the cornea by peripheral 
blood monocytes [35]. Overall, these most recent RNA-
seq studies, as well as our work, suggest an important role 
for native immune cells in the cornea, although further 
details need to be elucidated.
Similar to RNA-seq, there are only a few studies on FC 
analysis of human corneal tissue or whole corneal grafts. 
The first protocols for a respective FC analysis were es-
tablished in mice which have a much thinner corneal 
stroma layer than humans, allowing for easier cell har-
vesting [10]. Two more recent studies, which examined 
human tissue, focused on herpetic infections of the cor-
nea [34] and on subtypes of dendritic cells [36], whereby 
only the first study analyses the dynamics of APCs over 
time and both studies contain only few samples. The 
small number of previous studies on human cornea be-
speaks the complexity of preparing corneal tissue for FC 
analysis although FC analysis is actually ideally suited to 
investigate the dynamics of APC – especially DCs and 
macrophages.
Macrophages take on a special position in the rejection 
of corneal grafts. In addition to infiltration of the graft, an 
accumulation of monocyte-derived macrophages devel-
ops in the anterior chamber of the eye [37]. This recruit-
ment of macrophages to the anterior chamber of the eye 
occurs in response to the recognition of allogeneic tissue 
by the recipient’s immune system. In vitro studies using 
human macrophages suggest that these cells not only 
contribute to the destruction of the transplanted tissue 
[37], but that they also contribute to the recognition of 
allogeneic corneal tissue in the very early stages of graft 
rejection [22]. Furthermore, animal studies in different 
mouse strains show that the phenotype of these macro-
phages determines the course of transplant rejection, 
whereby a more aggressive M1 macrophage phenotype 
seems to be associated with a worse outcome [38].
There is evidence in the literature for a decrease in 
APCs within human corneas as organ culture time in-
creases [39, 40]. Our data are in line with these observa-
tions and clearly show a time-dependent loss of macro-
phages as a fraction of total live cells, whereas the total cell 
numbers were largely stable. Previous studies suggest a 
correlation between APC loss and increased graft surviv-
al [29]. However, a prolonged organ culture time also 
tends to diminish the endothelial cell count, thus increas-
ing the risk of graft failure [41]. Therefore, a drastic exten-
sion of organ culture time does not seem to be reasonable 
in order to prevent graft rejection. Eliminating APCs in 
corneal grafts therefore seems to be another rational ap-
proach to reduce the risk of rejection after transplanta-
tion. Zhang et al. [42] depleted corneal CD45+ cells from 
corneal buttons in mice using ex vivo depletion strategies 
including a complement-dependent cytotoxicity ap-
proach. In their experiments, the authors were able to re-
duce cells expressing CD45 by up to 70%. However, the 
depletion of CD45+ cells in grafts did not improve graft 
survival rates in a murine keratoplasty model. Therefore, 
it was suggested that the donor APCs participate in toler-
Fig. 4. Polarization of human corneal macrophages especially 
monocyte-derived cells. a Corneal cell counts after the respective 
treatment (each point represents an individual cornea) showed 
statistically significant increased cell counts for corneas treated 
with IL-10 (one-way ANOVA p < 0.05). For analyzing macro-
phages, the cell marker expression was normalized to 50,000 live 
cells. b Macrophage cell count showed no statistical differences 
among the different groups. c The percentage of CD45+/CD11b+/
CD14+/CD68+ macrophages after treatment revealed an altered 
macrophage phenotype for CD163+ cells after treatment with IL-
10 (*p < 0.05, one-way ANOVA).
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ance induction [43, 44]. Radical elimination of donor 
APCs from the graft may have affected tolerance induc-
tion and led to increased inflammation. Therefore, chang-
ing the phenotype from a pro-inflammatory to an anti-
inflammatory regulatory profile, rather than eliminating 
these cells, could be a valid alternative approach.
Due to its dense arrangement of fibrils and its greater 
corneal thickness compared to rabbits and mice [45, 46], 
the human cornea was inaccessible for a long time for ob-
taining single-cell suspensions for FC analyses. FC analy-
ses of native DCs in human corneal single-cell suspen-
sions have been reported before [34, 36]. To gain more 
insights into the myeloid cell composition of the cornea 
we addressed macrophage subtypes in human corneas 
and the possibility of a therapeutic modulation of their 
phenotype. Such treatment of donor corneas was shown 
to reduce corneal transplant rejection rates in animal 
models [31, 47], but respective data on human tissue are 
lacking.
In FC analysis of corneal tissue, we observed an in-
crease in the total number of cells per cornea on stimula-
tion with IL-10. This could be explained by an antiapop-
totic effect as well as by the proliferation of cells in re-
sponse to stimulation with IL-10 [48, 49]. In our study, no 
clear cell population emerged that would explain this ef-
fect, quite to the contrary CD45+ CD11b+ CD14+ CD68+ 
macrophages tended to be reduced in the IL-10 group. In 
addition to an investigation of other APC populations 
such as DCs, it would also be important to analyze adap-
tive immune cells, especially CD8+ T cells – in future stud-
ies. Ambarus and coworkers polarized human peripheral 
blood monocytes (PBMC) in vitro with IFN-γ, IL-4, and 
IL-10, and concluded that IL-4-polarized macrophages 
upregulate CD206, whereas IL-10-polarized macrophages 
upregulate CD163 [50]. Interestingly, our experiments 
also revealed increased expression of CD163 in macro-
phages within the human cornea upon stimulation with 
IL-10. According to a previous selection of CD45+ cells, 
M1 macrophages seem to be less sensitive to changes than 
M2 macrophages. However, this observation requires fur-
ther investigation in more advanced studies. For the sake 
of completeness, it should be noted that without prior 
CD45 selection, cells did show reduced expression of pro-
inflammatory markers upon stimulation with IL-10 or 
IL-4/IL-13. This illustrates that interactions of interleu-
kins with corneal immune cells seem to be rather complex. 
Further studies investigating different immune cells in 
this context will therefore be necessary. It will also be es-
sential to clarify the biological relevance of modifying in-
dividual cell types in preventing rejection. Certainly, a 
multiarm approach targeting different immune cell types 
is preferable to the modification of single cell types.
We identified only a small population of CD86+ cells 
in a few, but not in all, samples. This is consistent with a 
study by Lužnik, reporting on only a very small percentage 
of CD86+ cells in the central area of the human cornea 
[36]. However, in our study the discrimination of CD86-
positive and negative populations was vague. CD86 should 
therefore probably only be used with caution as a marker 
for the differentiation of various macrophage subtypes in 
the context of FC studies in corneal tissue.
Our study is limited by the fact that our FACS protocol 
does not allow for differentiation between resident mac-
rophages and infiltrating monocyte-derived macro-
phages. Signs of the presence of a major monocyte popu-
lation did not emerge in our RNA-seq data, which ap-
pears to be in line with other published data in this field 
[2, 35].
In summary, our data clearly illustrate the feasibility of 
FC-based quantitative analysis and characterization of 
innate immune cell phenotypes in human corneas. This 
technique allows the evaluation of therapeutic priming of 
innate immune cells in cultured human corneal tissue. 
Finally, we provide a strategy to translate a stimulus-de-
pendent fine-tuning of the myeloid compartment into a 
reduced transplant rejection rate in patients.
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